SCHEMBL20073840

SCHEMBL20073840

CN1C(=O)CCC(O)CCc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.44
SRD5A1 P18405 5/20 0.43
CHRM2 P08172 2/20 0.42
CHRM4 P08173 2/20 0.42
CHRM1 P11229 2/20 0.42
CHRM3 P20309 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MTNR1A P48039 3/20 0.41
TSHR P16473 2/20 0.41
DRD4 P21917 3/20 0.41
DRD2 P14416 2/20 0.41
CHRM5 P08912 1/20 0.40
DRD3 P35462 1/20 0.40
RIPK1 Q13546 1/20 0.39
BRPF1 P55201 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL761220 0.81 SRD5A1 (0.54) SRD5A1CHRM2CHRM4CHRM1CHRM3
Hydrochloric Acid SCHEMBL27632990 0.79 SRD5A1 (0.53) SRD5A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL677619 0.78 MEN1 (0.50) NOTUMSRD5A1TSHRBRPF1
SCHEMBL29946500 0.78 MEN1 (0.50) NOTUMSRD5A1BRPF1
SCHEMBL678115 0.78 MEN1 (0.50) NOTUMSRD5A1BRPF1
SCHEMBL19224516 0.77 BRD4 (0.44) NOTUMRAB9AMTNR1ATSHRDRD4
SCHEMBL20073949 0.75 KMT2A (0.46) NOTUMNPC1RAB9ATSHR
SCHEMBL21120469 0.73 MEN1 (0.47) NOTUMSRD5A1BRPF1
SCHEMBL25556401 0.73 DRD4 (0.48) SRD5A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL13502655 0.73 DRD4 (0.48) SRD5A1CHRM2CHRM4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018069732-A1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LIMITED (GB) 2018-04-19 WO disclosed